Avalon Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.2K Hold
613
﹤0.01% 280
2025
Q4
$48.4K Sell
613
-5
-0.8% -$392 ﹤0.01% 285
2025
Q3
$49.4K Buy
618
+26
+4% +$2.22K ﹤0.01% 324
2025
Q2
$53.8K Sell
592
-288
-33% -$26.3K ﹤0.01% 249
2025
Q1
$82.5K Buy
880
+180
+26% +$16.1K 0.01% 203
2024
Q4
$63.6K Buy
700
+48
+7% +$4.58K ﹤0.01% 202
2024
Q3
$67.7K Sell
652
-40
-6% -$4.08K 0.01% 192
2024
Q2
$67.2K Hold
692
0.01% 189
2024
Q1
$62.3K Hold
692
0.01% 203
2023
Q4
$55.2K Hold
692
0.01% 204
2023
Q3
$49.2K Sell
692
-40
-5% -$2.99K ﹤0.01% 192
2023
Q2
$56.4K Sell
732
-80
-10% -$6.19K 0.01% 196
2023
Q1
$61K Buy
+812
New +$60.4K 0.01% 189

Other funds holding CL

Avalon Trust's CL Position: Q1 2026 in Review

Avalon Trust held its Colgate-Palmolive (CL) position steady in Q1 2026 at 613 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Avalon Trust first reported a position in CL in Q1 2023 and has held it in 13 quarters since. The position peaked at $82.5K in Q1 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Avalon Trust held 613 shares of Colgate-Palmolive worth $52.2K as of Q1 2026.
  • Avalon Trust left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up ﹤0.01% of Avalon Trust's portfolio in Q1 2026, its #280 holding.
  • Avalon Trust first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 13 quarters since.
  • Avalon Trust's Colgate-Palmolive position peaked at $82.5K in Q1 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.